IGF::OT::IGF Contract Award to Care Team Solutions, LLC: Using mHealth to Aid Opi

使用丁丙诺啡/纳洛酮的阿片激动剂药物治疗已知减少 非法使用鸦片类药物。然而，自我管理过程中药物管理不善和滥用 阿片类药物替代疗法(OST)抑制了疗效，同时加剧了复发， 住院和死亡率。面临的最不可避免的挑战之一是 治疗阿片类药物依赖(OD)的专业人员确保药物被视为 开了处方。为患者和医生提供有效监控的交互式工具集 并在OST期间促进遵守是该项目将满足的主要需求 地址。在移动健康(MHealth)解决方案中利用前瞻性的方法， 承包商将开发一款名为SubAID的智能手机应用程序(App)，以参与和 在OST期间支持患者和照顾者促进遵守行为并提供 及时评估遵守情况。

Opiate-agonist pharmacotherapy utilizing buprenorphine/naloxone is known to decrease illicit opiate use. However, poor medication management and misuse during self-managed opioid substitution therapy (OST) constrains efficacy, while aggrandizing relapse, hospitalizations and mortality. One of the most inescapable challenges confronted by professionals treating opioid dependence (OD) is assuring medications are taken as prescribed. Affording patients and physicians an interactive toolset to effectively monitor and promote adherence during OST represents a major unmet need that this project will address. Utilizing a forward-thinking approach in mobile health (mHealth) solutions, the Contractor will develop a smartphone application (APP), named SubAID, to engage and support patients and caregivers during OST to promote adherent behavior and provide timely assessment of adherence.